We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SDF:ASXSteadfast Group Limited Analysis

Data as of 2026-05-20 - not real-time

A$4.17

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

The stock is trading below its short‑term moving averages, indicating recent weakness, but the 20‑day SMA sits just under the 50‑day SMA, hinting at a possible crossover. The 200‑day SMA remains well above current levels, confirming a longer‑term downtrend. RSI hovers just above the neutral midpoint, implying limited momentum to the upside. The MACD line has edged above its signal and the histogram turned positive, a bullish technical signal. Beta is low, pointing to reduced market‑wide volatility exposure, while month‑to‑month volatility is elevated but not extreme. The price‑to‑earnings multiple is comfortably below the industry average, indicating relative cheapness. A dividend yield near five percent coupled with a payout ratio below two‑thirds supports sustainability, and free cash flow comfortably covers the dividend. The discounted cash flow model values the company at more than double the current price, implying substantial upside. Analyst consensus is a buy with a median target near six dollars. Liquidity has been slipping, with recent volume trending down, which could pressure short‑term moves. Overall the combination of valuation gap, dividend appeal, and emerging technical support creates a compelling entry point.
Investors should weigh the undervaluation and strong dividend against the bearish longer‑term trend and liquidity considerations before deciding on a position.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • MACD bullish crossover
  • Attractive dividend yield
  • Undervaluation per DCF

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF upside potential
  • Revenue growth momentum
  • Strong cash‑flow coverage

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Long‑term valuation gap
  • Stable dividend policy
  • Low beta and defensive sector positioning

Key Metrics & Analysis

Financial Health

Revenue Growth14.90%
Profit Margin16.13%
P/E Ratio13.0
ROE16.48%
ROA7.38%
Debt/Equity76.27
P/B Ratio2.0
Op. Cash FlowA$530.0M
Free Cash FlowA$582.3M
Industry P/E16.5

Technical Analysis

TrendBearish
RSI51.7
SupportA$3.87
ResistanceA$4.39
MA 20A$4.13
MA 50A$4.19
MA 200A$5.15
MACDBullish
VolumeDecreasing
Fear & Greed Index89.18

Valuation

Fair ValueA$11.19
Target PriceA$5.94
Upside/Downside42.51%
GradeUndervalued
TypeBlend
Dividend Yield4.80%

Risk Assessment

Beta0.45
Volatility20.38%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.